返回
Microfluidic systems for cancer diagnostics
DOI:10.1016/j.copbio.2019.11.022.png)
摘要
En 中文
Although not employed in the clinic as of yet, microfluidic systems are likely to become a key technology for cancer diagnostics and prognosis. Microfluidic devices have been developed for the analysis of various biomarkers including circulating tumor cells, cell-free DNA, exosomes, and proteins, primarily in liquid biopsies such as serum, plasma, and whole blood, avoiding the need for tumor tissue biopsies. Here, we summarize microfluidic technological advances that are used in cancer diagnosis, prognosis, and to monitor its progression and recurrence, that will likely lead to personalized therapies. In some cases, integrated microfluidic technologies, coupled with biosensors, are proving to be more sensitive and precise in the detection of cancer biomarkers than conventional assays. Based on the current state-of-the-art and the rapid progress over the past decade, we also briefly discuss the next evolutionary steps that these technologies are likely to take.
Keyword:
CIRCULATING TUMOR-CELLS
LABEL-FREE
PROTEIN BIOMARKERS
EFFICIENT CAPTURE
NUCLEIC-ACIDS
TISSUE BIOPSY
DIGITAL PCR
EXOSOMES
LIQUID
SEPARATION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7
论文数:
5.0K
被引数:
1.9W
机构
引用论文
A microfluidic device for label-free, physical capture of circulating tumor cell clusters用于无标记,物理捕获循环肿瘤细胞簇的微流控设备
NATURE METHODS
IF32.1
Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles
NATURE COMMUNICATIONS
IF15.7
Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating
LAB ON A CHIP
IF5.4
A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis
Lab on a Chip
IF5.4
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer循环肿瘤细胞的全外显子组测序为转移性前列腺癌提供了一个窗口
NATURE BIOTECHNOLOGY
IF41.7
A Digital-Analog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples
ACS NANO
IF16

